286 related articles for article (PubMed ID: 30353300)
1. High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson's disease.
Baran A; Bulut M; Kaya MC; Demirpençe Ö; Sevim B; Akıl E; Varol S
Neurol Sci; 2019 Jan; 40(1):167-173. PubMed ID: 30353300
[TBL] [Abstract][Full Text] [Related]
2. [Changes in serum high mobility group box-1 protein and high-sensitivity C-reactive protein in patients with acute cerebral infarction and their clinical significance].
Zhou P; Li YQ; Li WD; Han TS; Yang SJ; Yao YM; Zhang YY; Yu Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 May; 24(5):265-8. PubMed ID: 22587919
[TBL] [Abstract][Full Text] [Related]
3. Is there an association between the level of high-sensitivity C-reactive protein and idiopathic Parkinson's disease? A comparison of Parkinson's disease patients, disease controls and healthy individuals.
Song IU; Kim JS; Chung SW; Lee KS
Eur Neurol; 2009; 62(2):99-104. PubMed ID: 19521085
[TBL] [Abstract][Full Text] [Related]
4. The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson's disease.
Akıl E; Bulut A; Kaplan İ; Özdemir HH; Arslan D; Aluçlu MU
Neurol Sci; 2015 Mar; 36(3):423-8. PubMed ID: 25288159
[TBL] [Abstract][Full Text] [Related]
5. Is neuroinflammation involved in the development of dementia in patients with Parkinson's disease?
Song IU; Kim YD; Cho HJ; Chung SW
Intern Med; 2013; 52(16):1787-92. PubMed ID: 23955613
[TBL] [Abstract][Full Text] [Related]
6. Elevated Serum High-Mobility Group Box-1 Protein Level Is Associated with Poor Functional Outcome in Ischemic Stroke.
Tsukagawa T; Katsumata R; Fujita M; Yasui K; Akhoon C; Ono K; Dohi K; Aruga T
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2404-2411. PubMed ID: 28645523
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of high mobility group box 1 protein as a presurgical diagnostic marker reflecting the severity of acute appendicitis.
Wu C; Sun H; Wang H; Chi J; Liu Q; Guo H; Gong J
Scand J Trauma Resusc Emerg Med; 2012 Sep; 20():61. PubMed ID: 22947457
[TBL] [Abstract][Full Text] [Related]
8. Association of maternal serum high sensitive C-reactive protein level with body mass index and severity of pre-eclampsia at third trimester.
Ertas IE; Kahyaoglu S; Yilmaz B; Ozel M; Sut N; Guven MA; Danisman N
J Obstet Gynaecol Res; 2010 Oct; 36(5):970-7. PubMed ID: 20722986
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin L activity correlates with proteinuria in chronic kidney disease in humans.
Cao Y; Liu X; Li Y; Lu Y; Zhong H; Jiang W; Chen AF; Billiar TR; Yuan H; Cai J
Int Urol Nephrol; 2017 Aug; 49(8):1409-1417. PubMed ID: 28534128
[TBL] [Abstract][Full Text] [Related]
10. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
Koc M; Karaarslan O; Abali G; Batur MK
Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
[TBL] [Abstract][Full Text] [Related]
11. Association between high-sensitivity C-reactive protein and risk of early idiopathic Parkinson's disease.
Song IU; Chung SW; Kim JS; Lee KS
Neurol Sci; 2011 Feb; 32(1):31-4. PubMed ID: 20532580
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum autoantibody against high mobility group box 1 as a potent surrogate biomarker for amyotrophic lateral sclerosis.
Hwang CS; Liu GT; Chang MD; Liao IL; Chang HT
Neurobiol Dis; 2013 Oct; 58():13-8. PubMed ID: 23639787
[TBL] [Abstract][Full Text] [Related]
13. The role of high-sensitivity C-reactive protein levels in functional outcomes in patients with large-artery atherosclerosis and small-artery occlusion.
Hou D; Liu J; Feng R; Gao Y; Wang Y; Wu J
Neurol Res; 2017 Nov; 39(11):981-987. PubMed ID: 28749740
[TBL] [Abstract][Full Text] [Related]
14. High expression of the HMGB1-TLR4 axis and its downstream signaling factors in patients with Parkinson's disease and the relationship of pathological staging.
Yang Y; Han C; Guo L; Guan Q
Brain Behav; 2018 Apr; 8(4):e00948. PubMed ID: 29670828
[TBL] [Abstract][Full Text] [Related]
15. Serum hs-CRP levels are increased in de Novo Parkinson's disease independently from age of onset.
Song IU; Cho HJ; Kim JS; Park IS; Lee KS
Eur Neurol; 2014; 72(5-6):285-9. PubMed ID: 25323302
[TBL] [Abstract][Full Text] [Related]
16. High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins.
de Souza AW; van der Geest KS; Brouwer E; Pinheiro FA; Oliveira AC; Sato EI; Andrade LE; Bijl M; Westra J; Kallenberg CG
Arthritis Res Ther; 2015 Jun; 17(1):158. PubMed ID: 26062541
[TBL] [Abstract][Full Text] [Related]
17. Association between levels of high-sensitivity C-reactive protein in plasma and freezing of gait in Parkinson's disease.
Liu J; Yin W; Zhou C; Zhu Y; Gu M; Liu B; Ren H; Yang X
Aging Clin Exp Res; 2022 Aug; 34(8):1865-1872. PubMed ID: 35471697
[TBL] [Abstract][Full Text] [Related]
18. High-Mobility Group Box-1 Is Associated With Obesity, Inflammation, and Subclinical Cardiovascular Risk Among Young Adults: A Longitudinal Cohort Study.
Chen L; Zhu H; Su S; Harshfield G; Sullivan J; Webb C; Blumenthal JA; Wang X; Huang Y; Treiber FA; Kapuku G; Li W; Dong Y
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2776-2784. PubMed ID: 32814439
[TBL] [Abstract][Full Text] [Related]
19. Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease.
Andican G; Konukoglu D; Bozluolcay M; Bayülkem K; Firtiına S; Burcak G
Acta Neurol Belg; 2012 Jun; 112(2):155-9. PubMed ID: 22426659
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of serum high-mobility group protein box 1 in children with Henoch-Schönlein purpura].
Wang FY; Jiang XM; Lu M
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Aug; 17(8):792-5. PubMed ID: 26287340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
